US · AORT
Artivion, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Kennesaw, GA 30144
- Website
- artivion.com
Price · as of 2025-12-31
$36.21
Market cap 1.84B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $51.99 | +43.58% |
| Intrinsic Value(DCF) | $16.84 | -53.49% |
| Graham-Dodd Method(GD) | $5.36 | -85.2% |
| Graham Formula(GF) | $4.56 | -87.42% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $5.12 | $34.35 | $0.00 | $5.62 | $2.85 |
| 2012 | $5.87 | $31.57 | $0.00 | $5.04 | $5.27 |
| 2013 | $9.64 | $37.26 | $0.00 | $6.31 | $8.80 |
| 2014 | $10.13 | $49.15 | $0.00 | $4.55 | $2.89 |
| 2015 | $10.76 | $34.91 | $0.00 | $4.07 | $1.28 |
| 2016 | $16.30 | $38.89 | $0.63 | $5.79 | $10.39 |
| 2017 | $21.70 | $44.84 | $0.00 | $3.31 | $1.47 |
| 2018 | $29.21 | $51.59 | $22.78 | $1.91 | $0.00 |
| 2019 | $25.12 | $38.64 | $8.14 | $2.90 | $0.60 |
| 2020 | $25.05 | $43.13 | $0.00 | $0.00 | $0.00 |
| 2021 | $19.61 | $57.23 | $0.00 | $0.00 | $0.00 |
| 2022 | $11.74 | $24.51 | $0.00 | $0.00 | $0.00 |
| 2023 | $20.02 | $194.82 | $0.00 | $0.00 | $0.00 |
| 2024 | $24.18 | $34.39 | $0.00 | $0.00 | $0.00 |
| 2025 | $38.55 | $51.99 | $0.00 | $5.36 | $4.55 |
AI valuation
Our deep-learning model estimates Artivion, Inc.'s (AORT) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $51.99
- Current price
- $36.21
- AI upside
- +43.58%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$16.84
-53.49% upside
Graham-Dodd
$5.36
-85.2% upside
Graham Formula
$4.56
-87.42% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| AORT | Artivion, Inc. | $36.21 | 1.84B | +44% | -53% | -85% | -87% | 178.92 | 3.90 | 3.96 | 40.14 | — | 46.42 | 61.28% | 6.06% | 2.21% | 2.70% | 2.80% | 1.17% | 0.65 | 1.01 | 2.99 | 1.66 | 4.62 | -16562.00% | 1359.00% | -10825.00% | -0.05% | 0.38 | -0.14% | 0.00% | 0.00% | 4.67% | 73.84 | -2167.72 | 4.47 | 3.19 |
| ADUS | Addus HomeCare Corporatio… | $103.53 | 1.91B | +45% | +163% | -70% | +52% | 20.25 | 1.79 | 1.36 | 13.48 | 87.39 | -140.67 | 32.47% | 9.74% | 6.74% | 9.33% | 8.85% | 6.73% | 0.19 | 14.46 | 1.80 | 1.56 | 0.83 | 2317.00% | 2321.00% | -10000.00% | 0.00% | 0.75 | 0.00% | 0.00% | 0.00% | 2.43% | 14.92 | — | 1.45 | 4.72 |
| ARDT | Ardent Health Partners, L… | $9.39 | 1.34B | +968% | -38% | +7% | +203% | 6.44 | 1.71 | 0.32 | 6.36 | 1.83 | 9.54 | 82.68% | 6.80% | 3.53% | 33.26% | 12.21% | 5.96% | 2.02 | 6.19 | 1.94 | 1.37 | 3.00 | 35143.00% | 1029.00% | 5128.00% | 6.60% | 0.33 | 4.65% | 0.00% | 0.00% | 12.10% | 9.01 | 28.67 | 0.61 | 2.13 |
| BKD | Brookdale Senior Living I… | $15.30 | 3.64B | +32% | -60% | — | — | -13.49 | -79.22 | 1.13 | 28.56 | -54.59 | -49.19 | 20.64% | 0.55% | -8.41% | -313.31% | 0.29% | -4.28% | -148.91 | 0.07 | 3.62 | 2.26 | 18.37 | 2472.00% | 477.00% | 73974.00% | -8.31% | 1.42 | -4.96% | 0.00% | 0.00% | 0.18% | 578.45 | -33.72 | 3.18 | -0.04 |
| COGT | Cogent Biosciences, Inc. | $38.85 | 6.31B | — | — | — | — | -7.99 | 4.13 | — | -6.03 | -218.46 | 4.13 | 0.00% | — | — | -73.70% | 2714.02% | -51.99% | 0.40 | -108.87 | 14.23 | 14.08 | 0.18 | 366.00% | — | 2766.00% | -10.12% | -4.13 | 2165.58% | 0.00% | 0.00% | 0.00% | -5.94 | -7.45 | — | 3.37 |
| INSP | Inspire Medical Systems, … | $64.51 | 1.87B | +102% | +157% | -20% | +62% | 13.09 | 2.44 | 2.09 | 25.07 | 7.29 | 2.44 | 85.39% | 5.59% | 15.95% | 19.77% | 13.05% | 16.95% | 0.04 | 371.93 | 6.08 | 4.46 | -1.12 | 17943.00% | 1360.00% | -1388.00% | 4.12% | 1.22 | 20.10% | 0.00% | 0.00% | 9.20% | 31.94 | 20.74 | 1.78 | 10.66 |
| ITGR | Integer Holdings Corporat… | $86.68 | 3.04B | -17% | -60% | -62% | -46% | 29.17 | 1.72 | 1.62 | 14.64 | — | -15.81 | 26.99% | 12.93% | 5.55% | 6.11% | 6.77% | 3.17% | 0.80 | 5.55 | 3.32 | 1.57 | 4.62 | -1500.00% | 798.00% | 554.00% | 3.51% | 0.85 | 3.62% | 0.00% | 0.00% | 1.67% | 18.29 | 41.68 | 2.36 | 2.45 |
| LFST | LifeStance Health Group, … | $7.24 | 2.82B | +311% | -6% | -90% | -93% | 285.23 | 1.81 | 1.94 | 34.29 | — | 55.12 | 28.53% | 1.80% | 0.68% | 0.65% | 1.24% | 0.45% | 0.13 | 2.20 | 1.65 | 1.37 | -0.69 | -11333.00% | 1385.00% | 2839.00% | 3.99% | 0.58 | 6.78% | 0.00% | 0.00% | 13.97% | 105.10 | 24.55 | 1.90 | 2.68 |
| LQDA | Liquidia Corporation | $31.02 | 2.7B | -15% | +1,142% | — | -41% | -8.95 | 15.09 | 83.34 | -9.61 | -24.05 | 16.61 | 58.00% | -866.63% | -931.65% | -209.35% | -667.62% | -74.80% | 1.58 | -9.71 | 4.43 | 4.29 | 0.47 | 3719.00% | -1997.00% | 12955.00% | -8.43% | -2.24 | -541.45% | 0.00% | 0.00% | 1.71% | -9.17 | -11.31 | 79.48 | 0.24 |
| PRCT | PROCEPT BioRobotics Corpo… | $22.69 | 1.27B | +83% | +106% | — | — | -15.10 | 3.94 | 4.69 | -15.09 | — | 3.95 | 63.70% | -33.71% | -31.02% | -24.89% | -74.26% | -18.34% | 0.14 | -11.69 | 6.85 | 5.62 | 2.93 | -171.00% | 3722.00% | -4370.00% | -4.04% | -0.74 | -41.71% | 0.00% | 0.00% | 0.44% | -11.64 | -20.71 | 3.92 | 5.16 |
| SSII | SS Innovations Internatio… | $4.76 | 921.64M | +1,445% | +6,162% | — | — | -85.61 | 121.83 | 79.40 | -93.41 | — | 121.83 | 40.93% | -91.90% | -92.74% | -138.00% | -81.31% | -56.44% | 1.35 | -19.50 | 1.29 | 0.36 | -1.00 | -3750.00% | 25120.00% | -3573.00% | -0.62% | -0.45 | -43.55% | 0.00% | 0.00% | 0.00% | -87.33 | -163.04 | 80.26 | 31.74 |
About Artivion, Inc.
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.
- CEO
- James Patrick Mackin
- Employees
- 1.6K
- Beta
- 1.58
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($16.84 ÷ $36.21) − 1 = -53.49% (DCF, example).